At a glance

Inspired by caring, powered by science

At Sobi, we are transforming the lives of people with rare and debilitating diseases. As a global biopharma company, we provide reliable access to innovative medicines in the areas of haematology, immunology, and specialty care.
 

Sobi in short:

• Operates in an international environment, with presence in around 30 countries, and delivers medicines to patients in many more
• Approximately 1,800 employees across Europe, North America, the Middle East, Asia, and Australia
• Global Head Office in Stockholm, Sweden
• In 2024, revenue amounted to SEK 26 billion
• The Sobi share (STO:SOBI) is listed on Nasdaq Stockholm.